ACE2 and viral infectious disease: Neutralizing antibodies (NAbs) provide real protective immunity as they play a crucial role in hampering the binding of the SARS-CoV-2 receptor-binding domain (RBD) of surface spike (S) protein to the human angiotensin-converting enzyme 2 (ACE2) receptor,9–12 blocking viral infection and minimizing disease severity.